Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 16 of 16 entries
View as:

Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

Phase: N/A Priority: Normal
NCT ID: NCT04764851 Org: User:
Start: 02/18/21 End: 05/07/21 Due: 05/07/22

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06021522 Org: User:
Start: 08/16/23 End: 03/31/27 Due: 03/31/28

Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)

Phase: N/A Priority: Normal
NCT ID: NCT04492956 Org: User:
Start: 10/02/20 End: 04/04/22 Due: 04/04/23

Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

Phase: N/A Priority: Normal
NCT ID: NCT02102698 Org: User:
Start: 03/31/14 End: 12/31/19 Due: 12/31/20

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

Phase: N/A Priority: Normal
NCT ID: NCT05615220 Org: User:
Start: 01/31/23 End: 02/04/25 Due: 02/04/26

Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension

Phase: N/A Priority: Normal
NCT ID: NCT04114539 Org: User:
Start: 10/04/19 End: 11/11/22 Due: 11/11/23

Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite

Phase: N/A Priority: Normal
NCT ID: NCT04902105 Org: User:
Start: 05/13/21 End: 07/06/21 Due: 07/06/22

Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

Phase: N/A Priority: Normal
NCT ID: NCT05334108 Org: User:
Start: 04/26/22 End: 08/26/22 Due: 08/26/23

Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble

Phase: N/A Priority: Normal
NCT ID: NCT01215357 Org: User:
Start: 10/31/10 End: 08/31/12 Due: 08/31/13

Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT04007991 Org: User:
Start: 06/28/19 End: 09/23/21 Due: 09/23/22

Drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT06194864 Org: User:
Start: 01/18/24 End: 05/22/24 Due: 05/22/25

Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization

Phase: N/A Priority: Normal
NCT ID: NCT05841160 Org: User:
Start: 03/15/23 End: 05/12/23 Due: 05/12/24

Study of the Absorption, Metabolism, and Excretion of [14C]-Ecopipam in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04881955 Org: User:
Start: 05/12/21 End: 09/07/21 Due: 09/07/22

Safety and Tolerability Comparison of Immediate and Controlled Release Formulations of Ecopipam

Phase: N/A Priority: Normal
NCT ID: NCT01408394 Org: User:
Start: 08/31/11 End: 05/31/12 Due: 05/31/13

Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease

Phase: N/A Priority: Normal
NCT ID: NCT01751802 Org: User:
Start: 12/31/12 End: 12/31/14 Due: 12/31/15

Food-effect Study of Ecopipam Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT06669091 Org: User:
Start: 11/05/24 End: 12/27/24 Due: 12/27/25